Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Oncology
|
June 17, 2021
miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma
Chenghong Wang, Guicai Zhu, Miaolin Yu, et al.
Biotechnology & Genetic Engineering Reviews
|
March 6, 2023
Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma
Xiaohai Guo, Changqing Tian, Gaili Liu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
March 4, 2022
Retracted: Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκB-PUMA Signaling
Qiang Yin, Shan Liu, Anbing Dong, et al.
Journal of Oncology
|
September 26, 2022
Study on the Application Value of Concurrent Chemoradiotherapy and Clinical Nursing Pathway for Postoperative Patients with Esophageal Cancer
Jinglei Yang, Xianzhong Zhang, Guangrong Yang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
July 1, 2016
Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling
Qiang Yin, Shan Liu, Anbing Dong, et al.
Minerva Medica
|
February 22, 2021
CircTMEM30A/hsa-miR-130a-3p regulates TNFα and promotes the malignant progression of COPD with primary lung cancer
Ning Shen, Deqin Yang, Junhui Hou, et al.
Oncology Letters
|
June 22, 2018
miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
Jianyong Liu, Bo Mi, Yi Wang, et al.
Plos One
|
December 15, 2022
Cost-effectiveness of PARP inhibitors in malignancies: A systematic review
Haiying Ding, Chaoneng He, Yinghui Tong, et al.
Free Radical Research
|
April 25, 2022
Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress <i>via</i> modulation of Keap1/Nrf2 signaling pathway
Yajun Qi, Shuang Fu, Donggen Pei, et al.
Expert Opinion on Drug Safety
|
May 16, 2024
Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study
Haiying Ding, Weiben Xu, Mengfei Dai, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Oncology
|
June 17, 2021
miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma
Chenghong Wang, Guicai Zhu, Miaolin Yu, et al.
Biotechnology & Genetic Engineering Reviews
|
March 6, 2023
Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma
Xiaohai Guo, Changqing Tian, Gaili Liu, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
March 4, 2022
Retracted: Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκB-PUMA Signaling
Qiang Yin, Shan Liu, Anbing Dong, et al.
Journal of Oncology
|
September 26, 2022
Study on the Application Value of Concurrent Chemoradiotherapy and Clinical Nursing Pathway for Postoperative Patients with Esophageal Cancer
Jinglei Yang, Xianzhong Zhang, Guangrong Yang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
July 1, 2016
Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling
Qiang Yin, Shan Liu, Anbing Dong, et al.
Minerva Medica
|
February 22, 2021
CircTMEM30A/hsa-miR-130a-3p regulates TNFα and promotes the malignant progression of COPD with primary lung cancer
Ning Shen, Deqin Yang, Junhui Hou, et al.
Oncology Letters
|
June 22, 2018
miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
Jianyong Liu, Bo Mi, Yi Wang, et al.
Plos One
|
December 15, 2022
Cost-effectiveness of PARP inhibitors in malignancies: A systematic review
Haiying Ding, Chaoneng He, Yinghui Tong, et al.
Free Radical Research
|
April 25, 2022
Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress <i>via</i> modulation of Keap1/Nrf2 signaling pathway
Yajun Qi, Shuang Fu, Donggen Pei, et al.
Expert Opinion on Drug Safety
|
May 16, 2024
Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study
Haiying Ding, Weiben Xu, Mengfei Dai, et al.
Page
of 2